April 19, 2023 | 11:00 am ET | On-Demand Webinar |

Speakers:

  • Elizabeth Smalley, Director of Product Management and Data and Analytics, ArisGlobal
  • Anand Ananthakrishnan, Senior Director of Drug Safety and Pharmacovigilance, Blueprint Medicines, Cambridge, MA

Overview:
With safety signal case volumes increasing 30 to 50 percent annually, how are pharmacovigilance teams managing with today’s constrained budgets, and what can real-world data and advanced cognitive computing do for tomorrow? This webinar will feature pharmacovigilance industry experts from across life sciences as they discuss:

  • What trends and challenges are safety signal teams facing today and how are they currently managing these issues?
  • With 70% of biopharma seeing a maturity gap in safety signal analytics processing, what feasible steps will be taken toward improving safety signal analytics this year?
  • What can we really expect from Real-World Data, Real-World Evidence, and Advanced Cognitive Computing – and when?
  • What does the FDA’s adoption of Real-World Data and Real-World Evidence mean for the life sciences industry?
  • Join the featured speakers as they bring together top pharmacovigilance industry professionals to engage in this invaluable conversation on the challenges, successes and future innovations relevant to safety signal analytics. Don’t miss this important discussion, view it on-demand at the link below.

    Join to learn:

    • Industry trends and challenges in safety signal analytics
    • How teams are solving for these problems today
    • How real-world data and advanced cognitive computing are creating innovations now and in the future for safety signal analytics

    View On-Demand

    Share on LinkedIn

    Related Posts

    Discover NavaX

    the latest automation from LifeSphere